MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-DL-11-0046262
Premedium Pharmaceuticals Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹9.67 Cr
▲ 29% YoY
Net profit · FY 2025
₹1.49 Cr
Net margin 15.4%
EBITDA · FY 2025
₹1.55 Cr
EBITDA margin 16%
Authorised capital
₹22 Cr
Registered with MCA
Paid-up capital
₹21.79 Cr
Issued & subscribed
Satisfied charges
₹1 Cr
No open charges
Company age
8 yrs
Est. 2018
Employees · EPFO
12
Provident fund records
About Premedium Pharmaceuticals Private Limited
Data last updated:
Premedium Pharmaceuticals Private Limited is a private limited company based in Delhi, India, a subsidiary of Classic Industries And Exports Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 October 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24200DL2018PTC340319. Its GSTIN is 06AAKCP1334P1Z3 (Haryana). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹22 Cr and a paid-up capital of ₹21.79 Cr. It is led by directors including Dilip Birdi (Whole-Time Director) and Sanjiv Kumar Kothari.
Its last annual general meeting (AGM) was held on 27 June 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 14 Sector – 20 Dwarka, Delhi, India – 110075.
As per the financials filed for FY 2025, the company reported a revenue of ₹9.67 Cr, a growth of 29% compared to the previous year. For the same year it recorded a net profit of ₹1.49 Cr (net margin 15.4%) and EBITDA of ₹1.55 Cr (EBITDA margin 16%). Revenue has declined at a compounded annual rate (CAGR) of 39% over three years and 29% over five years.
The company has about 12 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Premedium Pharmaceuticals. As per MCA filings, the company has satisfied charges of ₹1 Cr on record. Court records list 38 cases involving the company, including 14 filed by the company and 24 filed against it; 8 cases are pending.
Premedium Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-11-0046262). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website premediumpharmaceuticals.com.
Company details
CIN U24200DL2018PTC340319
Registration Number 340319
Incorporation Date 09 October 2018
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 27 June 2025
Date of Balance Sheet 31 March 2025
Parent Company Classic Industries And Exports Limited
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-DL-11-0046262
Recognitions & Rankings of Premedium Pharmaceuticals
Contact details
Premedium Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its website is premediumpharmaceuticals.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No. 14 Sector – 20 Dwarka, Delhi, India – 110075
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Premedium Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Premedium Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Premedium Pharmaceuticals operates one associated brand: Premedium Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures pharmaceutical products for oncology, cardiology, and medical therapies. | premediumpharmaceuticals.com |
Business activity
The main business activity of Premedium Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Premedium Pharmaceuticals Private Limited, buy the company report.
Financials of Premedium Pharmaceuticals Private Limited
FY 2025 filings availablePremedium Pharmaceuticals Private Limited reported revenue of ₹9.67 Cr (up 29% YoY) for FY 2025.
Revenue · FY 2025
₹9.67 Cr ▲ 29%
Net profit · FY 2025
₹1.49 Cr margin 15.4%
EBITDA · FY 2025
₹1.55 Cr margin 16%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 29%
3 years · compounded
▼ 39%
5 years · compounded
▼ 29%
EBITDA CAGR growth
1 year
▲ 21%
3 years · compounded
▲ 32%
5 years · compounded
▲ 19%
Revenue rose 29% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 29%. EBITDA rose 21% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.55 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.49 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 16% | ||||
| Net Profit Margin | 15.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Premedium Pharmaceuticals Private Limited, buy the company report.
Board of directors of Premedium Pharmaceuticals Private Limited
Premedium Pharmaceuticals has 3 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjiv Kumar Kothari | Director | 09 Oct 2018 | 8 Years 0 Months | Current |
| Saras Malik | Director | 14 Aug 2019 | 7 Years 2 Months | Current |
| Dilip Birdi | Whole-Time Director | 30 Dec 2019 | 6 Years 10 Months | Current |
Peer comparison
Premedium Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Carewin Pharmaceuticals (Gujarat) Private Limited | ₹9.77 Cr (FY 2025) | 13.0% | Ahmedabad, Gujarat, India | |||
| Mcneil and Argus Pharmaceuticals Limited | ₹9.73 Cr (FY 2024) | -59.0% | Haryana, India | |||
| Premedium Pharmaceuticals Private Limitedthis company | ₹9.67 Cr (FY 2025) | ₹1.49 Cr | 15.4% | 29.0% | 12 | Delhi, India |
| Willmark Pharmaceuticals Private Limited | ₹9.49 Cr (FY 2025) | -7.0% | Punjab, India |
To see the full peer comparison of Premedium Pharmaceuticals Private Limited, buy the company report.
Auditor
Premedium Pharmaceuticals Private Limited is audited by S. C. V. & Co. LLP for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S. C. V. & Co. LLP | FY 2021 | 000235N/N500089 |
Shareholding
The shareholding of Premedium Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Premedium Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
None
Satisfied charges
₹1 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 13 Aug 2019 | 100286768 | Others | ₹1 Cr | Satisfied |
To see the full charge records of Premedium Pharmaceuticals Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Premedium Pharmaceuticals Private Limited has 38 court cases on record: 14 filed by Premedium Pharmaceuticals, 24 filed against it. 8 cases are pending and 30 are disposed.
Total cases
38
Filed by the company
14
Filed against the company
24
Pending
8
Disposed
30
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 22 | 10 | 5 |
| High courts | 9 | 7 | 3 |
| NCLAT | 5 | 5 | 0 |
| NCLT | 2 | 2 | 0 |
Cases on record (5 of 38)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Sirmaur, Himachal Pradesh | Civil miscellaneous application | Filed by the company against Tirupati Medicare | Pending |
| High Court of Delhi | Court case (CM(M)) | Filed by the company against M/S Pure and Cure Healthcare Pvt. Ltd. | Pending |
| District court, Panchkula, Haryana | Civil miscellaneous application | Filed against the company by Beta Drugs Limited | Pending |
| District court, Sirmaur, Himachal Pradesh | Court case (Suit for Recovery) | Filed against the company by Tirupati Medicare Ltd Through Kapil Makkar | Pending |
| High Court of Delhi | Commercial suit | Filed against the company by Akums Drugs and Pharmaceuticals Ltd | Pending |
To see the full case history of Premedium Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Premedium Pharmaceuticals Private Limited was last rated by Care on 03 Dec 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Care | 03 Dec 2020 |
To see the full credit ratings and regulatory alerts of Premedium Pharmaceuticals Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Premedium Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Premedium Pharmaceuticals Private Limited has a workforce of 12 employees on its EPFO records as of Mar 23, 2024, across 1 active EPFO establishment.
Employee count
12
Active EPFO establishments
1
Employee growth
-7.69%
GST
Premedium Pharmaceuticals has 3 GST registrations: 1 active and 2 cancelled or inactive.
Total GSTINs
3
Active
1
Cancelled / inactive
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAKCP1334P1Z3 | Haryana | Active | 13 Nov 2018 |
To see the full GST registrations and return filing status of Premedium Pharmaceuticals Private Limited, buy the company report.
Recent activity
Premedium Pharmaceuticals Private Limited has 9 board changes on record since 2018: 3 appointments and 6 cessations. The latest: Mohit Kumar Goel ceased to be Company Secretary on 07 Dec 2022.
AGM
Premedium Pharmaceuticals Private Limited last Annual general meeting of members was held on 27 Jun 2025 as per latest MCA records.
Filing
Premedium Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Charges
A charge registered on 13 Aug 2019 via Charge ID 100286768 with Others was fully satisfied on 13 Feb 2023.
Ceased
Mohit Kumar Goel ceased to be Company Secretary.
Charges
A charge with Others of Rs. 1.00 Cr registered on 13 Aug 2019 with Charge ID 100286768 was modified on 15 Oct 2022.
Ceased
Rakesh Haldia ceased to be Cfo(Kmp).
Appointed
Dilip Birdi was appointed as Whole-Time Director.
Ceased
Saras Malik ceased to be Additional Director.
Ceased
Devlina Chakravarty ceased to be Director.
Ceased
Onkar S Kanwar ceased to be Director.
Appointed
Saras Malik was appointed as Director.
Charges
A charge with Others amounted to Rs. 1.00 Cr with Charge ID 100286768 was registered on 13 Aug 2019.
3 earlier events are in the company report.
Frequently asked questions
Premedium Pharmaceuticals is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 October 2018 (8+ years old) and is registered under CIN U24200DL2018PTC340319.
Premedium Pharmaceuticals has 3 current directors:
- Dilip Birdi - Whole-Time Director
- Sanjiv Kumar Kothari - Director
- Saras Malik - Director
The latest financial statements of Premedium Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 27 June 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Premedium Pharmaceuticals is 06AAKCP1334P1Z3, registered in Haryana. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Premedium Pharmaceuticals is U24200DL2018PTC340319. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Premedium Pharmaceuticals has 38 court cases on record: 14 filed by the company and 24 filed against it. 8 are pending. Most are in the district courts.
Premedium Pharmaceuticals was incorporated on 09 October 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Premedium Pharmaceuticals by revenue are Carewin Pharmaceuticals (Gujarat) Private Limited, Mcneil and Argus Pharmaceuticals Limited, Willmark Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Mohit Kumar Goel ceased to be Company Secretary on 07 Dec 2022. Rakesh Haldia ceased to be Cfo(Kmp) on 30 Jun 2022. Dilip Birdi was appointed as Whole-Time Director on 30 Dec 2019. Premedium Pharmaceuticals has 9 board changes on record in total.
Yes, Premedium Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-DL-11-0046262).
Premedium Pharmaceuticals can be reached through the website premediumpharmaceuticals.com. Its registered office is in Delhi, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages